We are live on ! Find out more
CM

CM Management Portfolio holdings

AUM $120M
1-Year Est. Return 37.12%
This Fund
S&P 500
This Quarter Est. Return
+25.59%
1 Year Est. Return
+37.12%
3 Year Est. Return
+141.34%
5 Year Est. Return
+139.46%
10 Year Est. Return
AUM
$124M
AUM Growth
+$30.2M
Cap. Flow
+$9.62M
Cap. Flow %
7.73%
Top 10 Hldgs %
42.82%
Holding
77
New
12
Increased
24
Reduced
16
Closed
5

Sector Composition

1 Healthcare 44.16%
2 Financials 8.39%
3 Technology 8.19%
4 Industrials 7.86%
5 Materials 7.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SWN
76
DELISTED
Southwestern Energy Company
SWN
-325,000
Closed -$2.1M
BCEL
77
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
-350,000
Closed -$91.3K

Similar funds

CM Management's Q4 2023 Portfolio in Review

As of Q4 2023, CM Management held 77 positions worth $124M, up 32% from $94.2M the previous quarter. Its ten largest holdings account for 43% of the portfolio.

CM Management deployed $9.62M of net new capital in Q4 2023, opening 12 new positions and adding to 24 existing holdings. Its largest new stake was Royalty Pharma: 125,000 shares worth $3.51M.

By sector, the portfolio is most concentrated in Healthcare at 44% of assets, up from 38% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was National Healthcare, an estimated $3.45M trimmed.

  • CM Management's largest Q4 2023 buy was Royalty Pharma: 125,000 shares worth $3.51M.
  • CM Management added most to Organon & Co in Q4 2023, an estimated $1.5M increase.
  • CM Management's biggest Q4 2023 reduction was National Healthcare, cutting an estimated $3.45M.
  • CM Management fully exited Southwestern Energy Company in Q4 2023, selling an estimated $2.1M.
  • CM Management's ten largest holdings make up 43% of its $124M portfolio in Q4 2023.
  • CM Management opened 12 new positions and closed 5 in Q4 2023.
  • CM Management's portfolio value rose 32% quarter-over-quarter to $124M.

Based on CM Management's 13F filing for Q4 2023, filed 12 Feb 2024.